Research Repository

Quantitative proteome profiling of lymph node-positive vs. -negative colorectal carcinomas pinpoints MX1 as a marker for lymph node metastasis

Croner, RS and Stürzl, M and Rau, TT and Metodieva, G and Geppert, CI and Naschberger, E and Lausen, B and Metodiev, MV (2014) 'Quantitative proteome profiling of lymph node-positive vs. -negative colorectal carcinomas pinpoints MX1 as a marker for lymph node metastasis.' International Journal of Cancer, 135 (12). 2878 - 2886. ISSN 0020-7136

[img]
Preview
Text
Croner_et_al_2014_nihms-590129.pdf

Download (1MB) | Preview

Abstract

© 2014 UICC. We used high-resolution mass spectrometry to measure the abundance of more than 9,000 proteins in 19 individually dissected colorectal tumors representing lymph node metastatic (n = 10) and nonmetastatic (n = 9) phenotypes. Statistical analysis identified MX1 and several other proteins as overexpressed in lymph node-positive tumors. MX1, IGF1-R and IRF2BP1 showed significantly different expression in immunohistochemical validation (Wilcoxon test p = 0.007 for IGF1-R, p = 0.04 for IRF2BP1 and p = 0.02 for MX1 at the invasion front) in the validation cohort. Knockout of MX1 by siRNA in cell cultures and wound healing assays provided additional evidence for the involvement of this protein in tumor invasion. The collection of identified and quantified proteins to our knowledge is the largest tumor proteome dataset available at the present. The identified proteins can give insights into the mechanisms of lymphatic metastasis in colorectal carcinoma and may act as prognostic markers and therapeutic targets after further prospective validation.

Item Type: Article
Subjects: R Medicine > R Medicine (General)
Divisions: Faculty of Science and Health > Biological Sciences, School of
Faculty of Science and Health > Mathematical Sciences, Department of
Depositing User: Berthold Lausen
Date Deposited: 05 Sep 2014 12:33
Last Modified: 23 Jan 2019 02:15
URI: http://repository.essex.ac.uk/id/eprint/9965

Actions (login required)

View Item View Item